Status:
COMPLETED
Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction
Lead Sponsor:
Plastic Surgery Group AG by Prof. Jian Farhadi
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The success rate of autologous microsurgical breast reconstruction depends on adequate intraoperative and postoperative flap perfusion. Perfusion is optimized intraoperatively by a full hyperdynamic c...
Detailed Description
All consecutive female patients receiving unilateral autologous microsurgical breast reconstruction starting from quarter I 2020 will be administered a total of either 750 ml Red Bull® Energy Drink (i...
Eligibility Criteria
Inclusion
- Indication: Patients undergoing unilateral autologous microsurgical breast reconstruction by Prof. Dr. med. Jian Farhadi, Dr. med. Alessia Lardi or Dr. med. Doris Babst
- Female participants ≥ 18 and ≤ 70 years of age
- Able to give written informed consent prior to participation in the study, which includes ability to comply with the requirements and restrictions listed in the consent form.
Exclusion
- History of arterial hypertension\*
- History of cardiac rhythm disorder\*
- History of Diabetes mellitus\*
- History of gastric or duodenal ulcer\*
- History of hyperthyroidism or hypothyroidism\*
- Current use of antihypertensive drugs, antiarrhythmic drugs, thyroid hormones (e.g. Euthyrox)\*
- Allergy or intolerance to component of Red Bull® Energy Drink
- Not fulfilling inclusion criteria. \* as diagnosed by the GP in the referral letter
Key Trial Info
Start Date :
May 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04397419
Start Date
May 11 2020
End Date
January 1 2023
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Pyramide am See
Zurich, Canton of Zurich, Switzerland, 8034